Natural killer (NK) cells were discovered, only about 7 years ago, during studies of natural cell-mediated cytotoxicity. Attempts were being made to understand a puzzling series of observations in tumor bearers or in individuals immunized against tumors. Investigators expected to find specific cytotoxic activity against autologous tumor cells or against tumors of the same histologic or -etiologic type, and indeed they did find ,such activity in some studies with virusinduced tumors in rodents (1) and with some cancer patients (2) . HowtY&rI-phoid cells of entirelvnormal individuals alsoxes iumor cellso cell lines derived from tumors (3) . Much of the natural reactivity was found to be attributable to a particular subpopulation of lymphoid cells, now termed NK cells. Studies on NK cells have recently expanded into a broad and multifaceted area of research (4), stimulated by the increasing indications that these cells may play important roles in natural host resistance against cancer and infectious diseases.
Before considering the evidence for a possible role of NK cells in resistance against disease, we summarize the characteristics ofother, better known categories of inmmunologic effector cells and discuss their similarities with and differences from NK cells. Some of the general and functional characteristics of each cell type are given in Tables 1 and 2. tor cells for reactivity against tumors or microbial agents and will therefore not be discussed here. T cells are a major subpopulation of small, typical lymphocytes that are dependent on the thymus for their maturation and acquisition of functional activity. Their (24, 25) . In addition, they are rapidly activatable, within hours to 1 day, to considerably higher levels of cytotoxic activity (26) . Most of the activating factors are nonspecific and include lymphokines [for example, macrophage activating factor and interferon formacrophages (27) ], phorbol esters for both cell types (28) , and microbial products, particularly bacterial endotoxin for mouse macrophages (29) .
Normal macrophages or PMN's can also interact with, and have considerable cytotoxic effects against, IgG-antibody coated tumor cells (30) . Similarly, antibody-coated bacteria or other' particles are efficiently phagocytosed by these cells. A major aspect of the cytotoxic activity of both cell types relates to the myeloperoxidase-dependent generation of reactive oxygen species (26, 31) . However, this mechanism does not appear to be solely responsible for their microbicidal and antitumor cytotoxic effects, since the cells from myeloperoxidase-deficient patients with chronic granulomatous disease still have some cytotoxic activity (31) . Stimulation of macrophages and PMN's, in addition to leading to augmented cytotoxicity and phagocytosis, causes a variety of biochemical and other changes in these cells. Among the products of activated macrophages and PMN's are a variety of enzymes, which can be expressed on the cell surface or released from the cells and which may be involved in the mechanisms of cytotoxicity (32) . In addition, macrophages have been shown to produce a series of immunoregulating products, including lymphocyte activating D r F a r r a h C a n c e r C e n t e r . c o m
factor, which has activating effects on T cells (33) ; interferon (34); prostaglandins, particularly of the E series (PGE) (35) ; and colony-stimulating factor (CSF). (39) and the majority react (23) with some monoclonal antibodies (9.6, and 3A1) to T cell-associated antigens (6, 40) . Similarly, at least half of mouse NK cells were shown to express Thy 1 (41) and about 20 percent reacted with a monoclonal antibody to Lytl (42) . Also, the monoclonal antibody OX8, directed against a subpopulation of rat T cells with suppressor activity, reacts with a large proportion of rat NK cells (43) . NK cells also grow in response to TCGF (44, 45) and produce TCGF (46 phages and PMN's. In the human, each of these cell types reacts with OKM1 and antibodies to asialo GMI and Mac 1 (47) , and in the mouse, one group of investigators has detected a macrophage-associated antigen, Mph 1, on a considerable proportion of NK cells (48) .
Particularly because of the confficting evidence as to the relation of NK cells to well-known categories of lymphoid cells, much effort has been directed toward the identification of markers restricted to, or at least highly selective for, NK cells. (59) .
The nature of target cell recognition by NK cells seems to be intermediate between the exquisite specificity of T cells and the ill-defined or absent specificity of macrophages or PMN's (60) D r F a r r a h C a n c e r C e n t e r . c o m 'documented is the ability of NK cells to produce interferon (61, 67) . In recent studies with highly enriched populations of human LGL, various tumor cell lines, viruses, mitogens, and bacterial and other adjuvants were shown to induce considerable production of interferon after culture overnight (61 D r F a r r a h C a n c e r C e n t e r . c o m
Most of the evidence for a role of NK cells in vivo relates to resistance against the growth of NK-susceptible tumor cell lines in vivo. The major approach has been to look for correlations between resistance in vivo to the growth of implanted tumor cell lines and the levels of NK activity in the recipient animals. In a variety of situations, tumors have grown less we ii w high NK activity than in those with low activity (71) . Furthermore, it has been possible to transfer increased resistance against tumor growth, and increased clearance of intravenously or subcutaneously inoculated radioactively labeled tumor cells, by transfer of NK cell-enriched populations or of bone marrow precursors of NK cells (72).
Although such results are encouraging, they do not indicate whether NK cells also can have a similar role in defense against growth and metastasis of spontaneous or carcinogen-induced primary tumors. Much less evidence for this issue is available. However, it has been found that most spontaneous mammary tumors of C3H mice (73) and spontaneous lymphomas in AKR mice (74) have detectable, albeit low, susceptibility to lysis by NK cells. Similarly, some human leukemias, a myeloma, and some carcinomas, sarcomas, and melanomas (75-78) have been significantly lysed by NK cells. Such lysis has been appreciably augmented, and thereby evident with a higher proportion of tumors, when the effector cells were pretreated with interferon (76) (77) (78) . As further support for the ability of NK cells to recognize primary tumor cells, Ortaldo et al. (79) showed that a variety of human tumor cells could inhibit the lysis of radioactively labeled K562 cells.
Most of these positive results were obtained with NK cells from normal allogeneic donors. In fact Vanky et al. (77) detected NK reactivity only against allogeneic human tumor cells and concluded that the NK cells of the tumor-bearing individual lacked the ability to recognize the autologous tumor cells. They postulated that recognition of foreign histocompatibility antigens was involved in lysis by NK (73) , and some cancer pa- 28 tients also have had detectable, interferon-augmentable, NK activity against their autologous tumor cells (78) .
The reasons for the discrepancies among the human studies are not clear. The positive results were obtained with ovarian carcinoma cells, mainly in 20-hour cytotoxicity assays (78) , whereas the allo-restricted results involved other types of tumors, tested only in 4-hour assays. The greater sensitivity of the prolonged assay would seem sufficient to account for the differences. In addition, it is possible that the subpopulation of NK cells that is required to interact with certain types of tumors may be selectively inhibited in the autologous tumorbearing host.
Another line of evidence indicating that NK cells may interact in vivo with autologous primary tumor cells is the demonstration that NK cells can enter and accumulate at the site of tumor growth. NK cells have been detected in small spontaneous mouse mammary carcinomas (82) and in small primary mouse tumors induced by murine sarcoma virus (82, 83) . In contrast, NK activity has usually been undetectable in large tumors in mice (82) or in clinical specimens of tumors. This may be due, at least in part, to the presence of suppressor cells, which have been demonstrated in some cell suspensions from some tumors (82, 84) .
Several pieces of evidence suggest that NK cells may be involved in surveillance against primary tumors. One of the major predictions of the immune surveillance theory is that tumor development should be associated with, and in fact be preceded by, depressed immunity. Several observations fit this prediction: (i) Patients with the Chediak-Higashi syndrome, who have a selective and marked deficit in NK activity (85) , have a high incidence of lymphoproliferative diseases (86) . (ii) Similarly, in a colony of beige mice with an analogous selective deficit in NK activity (87), a high incidence of lymphomas was noted (88 (89) .
A related prediction of the immune surveillance theory is that carcinogenic agents cause depressed immune function, thereby impairing the ability of the host to reject the transformed cells. This postulate has been examined by many investigators in regard to the possible role of mature T cells and humoral immunity, and confficting results have been obtained (90) . In contrast, the initial and still fragmentary data on this point in relation to NK cells are promising: (i) Urethane, which produces lung tumors in only some strains of mice, caused transient and marked depression of NK activity in a susceptible strain but not in resistant strains (91) . Administration of normal bone marrow, which can reconstitute NK activity, to urethane-treated susceptible mice reduced the subsequent development of lung tumors (92, 93) . (ii) Multiple, low doses of irradiation of C57BL mice, which is highly effective in inducing leukemia in this strain, produced a substantial deficit in NK activity (94) . The depressed NK activity could be restored by transfer of normal bone marrow cells from C57BL mice but not from beige mice (93) , and such transfer of normal C57BL bone marrow has been reported to interfere with radiation-induced leukemogenesis (95 (98) . There are also some indications that natural genetic resistance to another herpes virus, Marek's disease virus in chickens, may be mediated by NK cells (99) . However, there is also evidence against a role for NK cells in resistance to some other viruses (100) .
Natural killer cells may also be involved in resistance against some other types of microbial infections. Recently, a correlation was found between levels of NK activity and resistance of mice to the protozoan parasite Babesia microti (101). A possible role for NK cells has also been found for natural resistance of SCIENCE, VOL. 214 D r F a r r a h C a n c e r C e n t e r . c o m mice to infection by the fungus Cryptococcus neoformans (102) .
In line with the evidence that NK cells can react against some normal cells, there is increasing evidence for a major role of NK cells in natural resistance against bone marrow transplants. For many years it has been recognized that mice have natural resistance to transplantation of normal bone marrow and that some of the characteristics of this phenomenon do not conform to the wellestablished rules governing transplantation of other tissues. With the development of information about the characteristics of NK cells, it has become clear that NK cells might account for this resistance to bone marrow transplants. Indeed, in a series of direct compansons between the characteristics of natural resistance to bone marrow transplants and of NK cells, an excellent correlation was found and it is now generally agreed that NK cells are the main effector cells for this phenomenon in vivo (103) , It is of interest that a relation has also been observed between NK cell activity and graft versus host disease (104, 105) .
Conclusions and Prospects
Natural killer cells represent an interesting and unusual type of effector cell. Research to date has led to a considerable level of understanding of the nature and characteristics of these cells, but has also raised a number of questions. For example, it would be of interest to determine more clearly the lineage of NK cells and their relation to the T cell and myelomonocytic lineages; the nature of the recognition receptors on NK cells and of the antigens on the target cells; the detailed mechanisms for the regulation of their activity; and the biochemical sequence of events that lead to their lysis of target cells. The recent finding of the intimate association between NK cells and LGL, and the concomitant ability to purify these cells and to expand their numbers in culture, have provided an excellent basis for further studies on these questions. It would also be of interest to determine the nature of the granules in LGL and whether these granules play an important role in their functions.
The data on the roles of NK cells in vivo suggest that these cells may be important in the first line of defense against tumor growth and against infection by some microbial agents. It is now necessary to determine more directly the role of NK cells in immune surveillance.
Ideally, one would like to show in- 2 OCTOBER 1981 creased tumorigenesis when NK activity is selectively depressed and reduced tumor formation when such deficiencies are selectively reconstituted or normal levels of reactivity are selectively augmented. However, there are several practical problems in conducting such experiments. In addition to the long time needed for such studies and difficulties in identifying the most relevant experimental carcinogenesis models, completely selective and sustained alterations of NK activity are not easily found or produced. Furthermore, the NK-depressive effects of carcinogens themselves might eliminate the differences between normal and NK-deficient individuals. The most convincing procedure might be to reconstitute animals with depressed NK activity, by adoptive transfer of purified NK cells or their precursors, and determine the effects on carcinogenesis or on microbial infectionslif a major role for NK cells in resistance against tumor growth or other diseases can be substantiated, this might lead to alternative strategies for immunoprevention or immunothera-
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The findings of a major role for NK cells in natural resistance against bone marrow transplants in mice have considerable implication for clinical bone marrow transplantation. If NK cells can be shown to be similarly involved in rejection of human bone marrow transplants, some alterations in current procedures might be made to ensure sustained depression of NK activity, which might thereby improve graft survival.
